Komori
Other Disclosures4891TMS Co.,Ltd.Pharmaceuticals

Our Chairman of the Board, Hasumi Keiji (蓮見惠司), who is also a specially appointed professor at Tokyo University of Agriculture and Technology, will appear on NHK Eテレ’s program “The Villain’s Side of the Story.”

The company announced that its chairman is scheduled to appear on NHK E-Tele's program “The Villain's Case.” The program will explain black mold and the SMTP compound family related to the company's R&D products.

Worth reading
43Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

NHK E-Tele's “The Villain's Case”TMS-007(JX10)TMS-008SMTP compound family
Applicable field (uses covered by this announcement)

Black mold, the pharmacological effects of the SMTP compound family, thrombolytic activity, and pharmaceutical R&D

Launch date10:30–11:00 on Saturday, 12 September 2026 (scheduled broadcast). The rebroadcast is scheduled for 16 September, and NHK ONE streaming will be available until 11:00 on 19 September.
Relationship between the counterparty and the company
TMS Co.,Ltd.4891
Relationship with the Company

The company's chairman is scheduled to appear on the program as a guest and commentator.

CounterpartyNHK

Japan Broadcasting Corporation (NHK). The documents refer to NHK E-Tele and NHK ONE.

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

NHK E-Tele's “The Villain's Case” program website and the Fermentation Science Laboratory website of Tokyo University of Agriculture and Technology

Announced details
ItemDetails
Names of Products / Services CoveredNHK E-Tele's “The Villain's Case”, TMS-007(JX10), TMS-008, SMTP compound family
CounterpartyNHK
Counterparty overviewJapan Broadcasting Corporation (NHK). The documents refer to NHK E-Tele and NHK ONE.
Relationship with the CompanyThe company's chairman is scheduled to appear on the program as a guest and commentator.
Launch date10:30–11:00 on Saturday, 12 September 2026 (scheduled broadcast). The rebroadcast is scheduled for 16 September, and NHK ONE streaming will be available until 11:00 on 19 September.
Applicable areaBlack mold, the pharmacological effects of the SMTP compound family, thrombolytic activity, and pharmaceutical R&D
SourceNHK E-Tele's “The Villain's Case” program website and the Fermentation Science Laboratory website of Tokyo University of Agriculture and Technology
Items this document does not state (11)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company's R&D products TMS-007 (JX10) and TMS-008 belong to the SMTP compound family, which the chairman and others discovered in black mold while they were at Tokyo University of Agriculture and Technology.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Our Chairman of the Board, Hasumi Keiji (蓮見惠司), who is also a specially appointed professor at Tokyo University of Agriculture and Technology, will appear on NHK Eテレ’s program “The Villain’s Side of the Story.” | TMS Co.,Ltd. (4891) timely disclosure | Komori